QUALITY OF DATA IN PREGNANCY HEALTH RECORD: THE IMPORTANCE FOR THE NEONATOLOGIST

Rita Espírito Santo, Carolina Salgado, Sandra Valente, Joana Saldanha

Abstract


Introduction: The Pregnancy Health Record (PHR) is a functional tool that allows the sharing of pregnancy data among health care professionals. This information is particularly important in the assessment of the newborn immediately after delivery. The purpose of this study was to analyse the quality of these records.

Methods: PHR data were collected from a convenience sampling of puerperal women admitted in the Obstetrics Service between March and June 2014. The quality of the records was evaluated according to the recommendations of Direção Geral de Saúde (DGS). SPSS 20® was used for data analysis (statistically significant p<0.05)

Results: The final sample was composed by 468 puerperae. The pregnancy was monitored in 98% of the cases, 44% of which in a Health Care Center (HCC), 21% in a private obstetrician (PO), 24% in the hospital and 11% in multiple places. Correct records were found for blood type in 96% of the cases, blood count in 60%, gestational diabetes screening in 59%, group B streptococcus screening in 76%, ultrasounds in 87%, HIV in 64%, HBV in 72%, and for toxoplasmosis in 66%. No significant differences in these records considering the care unit where pregnancy was monitored. There was a statistically significant association between pregnancy surveillance in the HCC and correct records for syphilis and tetanus vaccination (p<0.001). Although the DGS does not recommend routine screening for CMV and VHC, a relationship between these serology records and pregnancy monitoring in PO was found (p<0.001 and p<0.03)

Conclusion: The majority of records were considered correct, however a greater completeness and uniformity of pregnancy records is still necessary, so that the paediatrician can have accurate pregnancy clinical information for the first observation of the newborn.


Keywords


Pregnancy health record; prenatal care; pregnancy complications; newborn health; maternal serum screening tests

Full Text:

PDF (Português)

References


United Nations. Millennium Declaration. United Nations Information Centre, Lisbon. DPI/2163-Portuguese-2001; 1-16.

Instituto Nacional de Estatística. A Mortalidade Infantil em Portugal. Destaque do INE 2001.

Neves JP, Ayres-de-Campos D. Mortalidade materna em Portugal desde 1929. Acta Obstet Ginecol Port 2012; 6: 94- 100.

Instituto Nacional de Estatística, IP. Estatísticas Demográficas 2014. INE, IP Lisboa- Portugal 2015; ISSN 0377-2284:65-71.

Direção Geral de Saúde. Boletim de Saúde da Grávida. Circular informativa nº16/DSMIA de 07/09/2001.

Diário da República. Obrigatoriedade do preenchimento dos Boletins de Saúde Infantil e Grávida. Despacho n.º 1/91 de 1 de Fevereiro 1991; 27: 1231.

Portela A. Saúde Materna – para quando? Saúde Infantil 1988; 10: 213-7.

Portela A. Ainda… Saúde Materna-para quando? Saúde Infantil 1992; 14:199-203.

Remoaldo P, Marinho A. O Boletim de Saúde da Grávidapara quando a sua completa utilização? Saúde Infantil 1997;19: 41-8.

Saldanha MJ. Utilidade do Boletim de Saúde da Grávida para a Avaliação do Recém-Nascido. Acta Pediatr Port 2004; 35: 43-7.

Salgado C, Espírito Santo R, Valente S, Saldanha J. Registo do boletim de saúde da grávida - 18 anos de evolução. Acta

Pediatr Port 2014; 45: S110-1.

Direção Geral de Saúde. Exames Laboratoriais na Gravidez de Baixo Risco. Norma nº037/2011 atualizada a 20/12/2013.

National Collaborating Centre for Women’s and Children’s Health. Antenatal care routine care for the healthy pregnant woman Clinical Guideline March 2008; 120-2.180-202.

UK Blood Transfusion Services. Guidelines for the Blood Transfusion Service. 6th ed. London; TSO; 2002.

Steer P, Alam MA, Wadsworth J, Welch A. Relation between maternal haemoglobin concentration and birth weight in different ethnic groups. BMJ 1995; 310: 489– 91.

Direção Geral de Saúde. Prevenção das formas graves de hemoglobinopatia. Circular informativa nº18/DSMIA de 07/09/2004.

Khellaf M, Loustau V, Bierling P, Michel M, Godeau B. Thrombocytopenia and pregnancy. Rev Med Interne 2012; 33: 446-52.

Poolsup N, Suksomboon N, Amin M. Effect of treatment of gestational diabetes mellitus: a systematic review and metaanalysis. PLoS One. 2014; 9:e92485. doi: 10.1371/journal.pone.0092485.

Crowther CA, Hiller JE, Moss jr, McPhee AJ, Jeffries WS, Robinson JS. Australian Carbohidrate Intolerance Study in Pregnant Women (ACHOIS). Effect of Treatment of Gestacional Diabetes on Pregnancy Outcomes. N Engl J Med 2005; 352: 2477-86.

Direção-Geral da Saúde. Diagnóstico e Conduta na Diabetes Gestacional. Norma n.º7/2011 de 31/1/2011.

De Santis M, De Luca C, Mappa I, Spagnuolo T, Licameli A, Straface G et al. Syphilis Infection during Pregnancy: Fetal Risks and Clinical Management. Infect Dis Obstet Gynecol 2012: 430-585.

Instituto Nacional de Estatística, IP. Casos notificados de doenças de declaração obrigatória (N.º) por Local de residência (NUTS - 2013), Sexo e Doenças de declaração obrigatória; Anual - INE, Casos Notificados de Doenças de Declaração Obrigatória. (Acedido em 15 Setembro 2015). Disponível em: https://www.ine.pt/xportal/xmain xpid=INE&xpgid=ine_indicadores&indOcorrCod=0008458&contexto=bd&selTab=tab2.

Alexander JM, Sheffield J, Sanchez PJ, Mayfield J, Wendel GD. Efficacy of treatment for syphilis in pregnancy. Obstet Gynecol 1999; 93:5-8.

Direção Geral de Saúde.;Programa Nacional de Vacinação 2012; 21/12/2011; Norma nº040/2011, atualizada a 26/01/2012.

World Health Organization (WHO) Regional Office for Europe. Eliminating measles and rubella. Framework for the verification process in the WHO European Region. Copenhagen: WHO Regional Office for Europe; 2012. (Acedido em 29 Setembro 2015). Disponível em: http://www.euro.who.int/__data/assets/pdf_file/0005/156776/e96153-Eng-final-version.pdf.

Kazemier BM, Koningstein FN, Schneeberger C, Ott A, Bossuyt PM, Miranda E, et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infect Dis. 2015; 15:1324-33.

Benitz WE, Gould JB, Druzin ML. Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review. Pediatrics 1999; 103:e78.

Centers for Disease Control and Prevention. Prevention of Perinatal Group B Streptococcal Disease. MMWR 2010; 59:3-23.

Direção Geral de Saúde. Norma nº023/2011.Exames Ecográficos na Gravidez de Baixo Risco. 29/09/2011. Atualizada a 21/05/2013.

Lito D, Francisco T, Salva I, Tavares MN, Oliveira R, Neto MT. Análise das Serologias para Infeções do Grupo TORCH e do Rastreio para Streptococcus do grupo B na População de Grávidas de uma Maternidade. Acta Med Port 2013; 26:549-54.

Lopes AP, Dubey JP, Moutinho O, Vilares A, Rodrigues M, Cardoso L, et al. Seroepidemiology of Toxoplasma gondii infection in women from the North of Portugal in their childbearing years. Epidemiol Infect 2012; 140: 872-7.

Bacalhau S, Timóteo C, Agro J. Perinatal transmission of hepatitis C virus - Santo André Hospital, Leiria 2002-2006. Acta Med Port 2010; 23: 391-8.

Paixāo P, Almeida S, Gouveia P, Vilarinho L, Vaz Osório R. Prevalence of human cytomegalovirus congenital infection in Portuguese newborns. Euro Surveill 2009; 14: 13-5.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.